InvestorsHub Logo
Followers 40
Posts 2944
Boards Moderated 0
Alias Born 02/08/2014

Re: NASDAQ2020 post# 362580

Monday, 11/29/2021 11:10:41 AM

Monday, November 29, 2021 11:10:41 AM

Post# of 410388
That is the problem we have zero idea. Nasrat said he reached out and contacted Pfizer to discuss anti-abuse technology. He used this information to prove to investors that he has not abandoned the idea of using Elite's anti-abuse technology. We have no idea whether he talked to anyone, or any idea what drug(s) the discussion was intended be about. He may have only called up and only given his contact information and asked someone to call him back. Until we have definitive information that shows Elite has a viable path in a relatively short period to an ADT drug (a year or two at most) that information is useless to me as an investor.

I stand by my statement that there is no known breakthrough drug on Elite's horizon.

Regardless it is so undervalued based on just its generics it is a low risk investment right now. If they pull a rabbit out of their hat and surprising us with a novel new ADT drug, that would be awesome. But no one should be investing in Elite with that expectation as a likely outcome.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News